Photo on left: Asm. Jerry Hill (D-San Mateo) delivers opening remarks. Photo on right: Maziar Movassaghi, Department of Toxic Substances Control.
Pictured from left to right: Panelists from "Setting the Environmental Regulatory Stage in California and Lessons Learned from Europe" Curtis Stephan, Edwards Lifesciences; Michael Whaley, Allergan; Ashley Taylor, Amgen Fremont; Sheri Prosch, Medtronic; Jeffrey Sickenger, KP Public Affairs; and Sandra Pizarro, CHI.
Click here to view more picture from CHI's Environmental Summit.
CHI held its first-ever Environmental Summit this last week at The Citizen Hotel in Sacramento, where Assembly Member Jerry Hill kicked off the day with welcome remarks stressing the importance of California’s biomedical industry and preserving the state’s natural beauty. Recognizing that in recent years, numerous legislative attempts to enact restrictive environmental requirements in California have threatened life sciences research and manufacturing jobs, CHI sought to convene experts from throughout the biomedical industry and public officials to discuss the measures and their potential implications.
More than 80 people attended the inaugural event held on the Metropolitan Terrace, which had beautiful views of the state capitol, and heard from speakers from Allergan, Edwards Lifesciences, Amgen, Pfizer, Amylin, Johnson & Johnson, Genentech and Stanford University, as well as public officials including Maziar Movassaghi, acting director of the Department of Toxic Substance Control (DTSC); Margo Reid Brown, acting director of the California Department of Resources Recycling and Recovery; and Assembly Member Wesley Chesbro (D-Arcata), gave participants a broad overview of what is new, what is changing and what to expect from major state environmental regulatory programs in California. Panel discussion topics focused on the state’s complex environmental regulatory structure, green chemistry, product stewardship, including medical sharps waste and pharmaceuticals in the environment, as well as nanotechnology. Maureen Gorsen, former director of the DTSC and currently with the law firm of Alston + Bird, delivered keynote comments at lunch.
The day wrapped up with a closing reception where attendees were able to discuss environmental issues with all panelists from the program.
CHI gratefully acknowledges its Gold Sponsors: Abbott, Amgen, Edwards Lifesciences, Genentech; Silver Sponsors: BioMarin, and Sanofi Aventis; and Reception Sponsor: Alston + Bird, LLP. CHI welcomes your participation in future discussions on the implications for environmental regulations and California’s ability to maintain its leadership in innovation. Contact Ritchard Engelhardt, associate director of government affairs (916-233-3490 or engelhardt@chi.org) for more information on how to get involved.
CHI-Advancing California biomedical research and innovation
CHI held its first-ever Environmental Summit this last week at The Citizen Hotel in Sacramento, where Assembly Member Jerry Hill kicked off the day with welcome remarks stressing the importance of California’s biomedical industry and preserving the state’s natural beauty. Recognizing that in recent years, numerous legislative attempts to enact restrictive environmental requirements in California have threatened life sciences research and manufacturing jobs, CHI sought to convene experts from throughout the biomedical industry and public officials to discuss the measures and their potential implications.
More than 80 people attended the inaugural event held on the Metropolitan Terrace, which had beautiful views of the state capitol, and heard from speakers from Allergan, Edwards Lifesciences, Amgen, Pfizer, Amylin, Johnson & Johnson, Genentech and Stanford University, as well as public officials including Maziar Movassaghi, acting director of the Department of Toxic Substance Control (DTSC); Margo Reid Brown, acting director of the California Department of Resources Recycling and Recovery; and Assembly Member Wesley Chesbro (D-Arcata), gave participants a broad overview of what is new, what is changing and what to expect from major state environmental regulatory programs in California. Panel discussion topics focused on the state’s complex environmental regulatory structure, green chemistry, product stewardship, including medical sharps waste and pharmaceuticals in the environment, as well as nanotechnology. Maureen Gorsen, former director of the DTSC and currently with the law firm of Alston + Bird, delivered keynote comments at lunch.
The day wrapped up with a closing reception where attendees were able to discuss environmental issues with all panelists from the program.
CHI gratefully acknowledges its Gold Sponsors: Abbott, Amgen, Edwards Lifesciences, Genentech; Silver Sponsors: BioMarin, and Sanofi Aventis; and Reception Sponsor: Alston + Bird, LLP. CHI welcomes your participation in future discussions on the implications for environmental regulations and California’s ability to maintain its leadership in innovation. Contact Ritchard Engelhardt, associate director of government affairs (916-233-3490 or engelhardt@chi.org) for more information on how to get involved.
CHI-Advancing California biomedical research and innovation
No comments:
Post a Comment